SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $157,000 | -10.3% | 13,100 | -6.4% | 0.06% | -26.3% |
| Q1 2021 | $175,000 | -19.7% | 14,000 | 0.0% | 0.08% | -15.6% |
| Q4 2020 | $218,000 | -42.9% | 14,000 | -65.3% | 0.09% | -53.8% |
| Q3 2020 | $382,000 | -39.5% | 40,400 | -42.6% | 0.20% | -44.8% |
| Q2 2020 | $631,000 | +84.0% | 70,400 | +30.6% | 0.35% | +57.6% |
| Q1 2020 | $343,000 | -40.3% | 53,900 | -21.5% | 0.22% | -38.6% |
| Q4 2019 | $575,000 | – | 68,700 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Golden State Equity Partners | 154,360 | $897,000 | 0.45% |
| Rhenman & Partners Asset Management AB | 761,429 | $4,424,000 | 0.44% |
| Lombard Odier Asset Management (Switzerland) SA | 860,702 | $5,001,000 | 0.39% |
| WASATCH ADVISORS LP | 10,576,997 | $61,452,000 | 0.30% |
| Rokos Capital Management LLP | 977,663 | $5,861,000 | 0.27% |
| KLK CAPITAL MANAGEMENT LLC | 44,323 | $258,000 | 0.26% |
| Long Focus Capital Management, LLC | 340,000 | $1,975,000 | 0.25% |
| Vanguard Capital Wealth Advisors | 33,380 | $193,000 | 0.14% |
| Fort Sheridan Advisors LLC | 73,978 | $430,000 | 0.13% |
| Delphia (USA) Inc. | 20,983 | $122,000 | 0.09% |